Brimaglo Eye Drops contain Brimonidine Tartrate Ophthalmic Solution 0.2%, indicated for the treatment of ocular hypertension and glaucoma. This medication helps lower elevated intraocular pressure (IOP), thereby reducing the risk of optic nerve damage and progressive vision loss. Brimonidine works by decreasing aqueous humor production while increasing uveoscleral outflow, resulting in effective and sustained reduction of intraocular pressure. It may be used as monotherapy or in combination with other pressure-lowering eye drops, depending on clinical requirements.
Brimonidine Tartrate 0.2% helps reduce intraocular pressure by decreasing aqueous humor production and enhancing fluid outflow from the eye.
Lowers Intraocular Pressure
Effectively reduces elevated eye pressure in glaucoma and ocular hypertension.
Protects Vision
Helps prevent optic nerve damage and vision loss.
Flexible Treatment Option
Can be used alone or in combination with other glaucoma medications.
Clinically Proven Therapy
Widely prescribed in ophthalmic practice.
Well-Tolerated Eye Drops
Suitable for use under medical supervision.
Use the eye drops exactly as prescribed by a healthcare professional. Avoid touching the dropper tip to prevent contamination.
May include eye redness, burning sensation, dry mouth, fatigue, or headache. Consult a healthcare professional if symptoms persist or worsen.
Globus Labs brings you WHO-GMP–certified, high-quality Brimonidine Tartrate Ophthalmic Solution sourced from reputed pharmaceutical manufacturers. Brimaglo Eye Drops is formulated to deliver safe, potent, and clinically trusted support.
Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.